APA (7th ed.) Citation

M, M., C, S., L, D. F., C, A., M, M., & M, R. (2025). Harnessing Venetoclax in NPM1-Mutated AML: A Path to Sustained Remission and Beyond. Cancers, 17(23), . https://doi.org/10.3390/cancers17233733

Chicago Style (17th ed.) Citation

M, Molica, Simio C, De Fazio L, Alati C, Martino M, and Rossi M. "Harnessing Venetoclax in NPM1-Mutated AML: A Path to Sustained Remission and Beyond." Cancers 17, no. 23 (2025). https://doi.org/10.3390/cancers17233733.

MLA (9th ed.) Citation

M, Molica, et al. "Harnessing Venetoclax in NPM1-Mutated AML: A Path to Sustained Remission and Beyond." Cancers, vol. 17, no. 23, 2025, https://doi.org/10.3390/cancers17233733.